Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.869 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8627 |
High Similarity |
NPD7819 |
Suspended |
0.8591 |
High Similarity |
NPD2534 |
Approved |
0.8591 |
High Similarity |
NPD2533 |
Approved |
0.8591 |
High Similarity |
NPD2532 |
Approved |
0.8462 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8387 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8387 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8312 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8151 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.8137 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8101 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8089 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8089 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8075 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD5711 |
Approved |
0.8025 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8025 |
Intermediate Similarity |
NPD5710 |
Approved |
0.8 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7947 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7937 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7922 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7892 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7861 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7848 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7843 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7836 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7806 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7764 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7756 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7738 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7733 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7733 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7727 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7727 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7718 |
Intermediate Similarity |
NPD943 |
Approved |
0.7716 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7703 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7702 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7697 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7662 |
Intermediate Similarity |
NPD2800 |
Approved |
0.766 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7647 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7632 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7602 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7595 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7593 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7582 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7582 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7576 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7548 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7548 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7546 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7518 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7457 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7453 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7453 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7438 |
Intermediate Similarity |
NPD920 |
Approved |
0.7434 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7434 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD37 |
Approved |
0.7421 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7419 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7412 |
Intermediate Similarity |
NPD7228 |
Approved |
0.741 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD919 |
Approved |
0.7405 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7397 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7394 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7391 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7391 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7384 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7374 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7374 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7368 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7348 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7348 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7345 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7321 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7268 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7255 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7249 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7249 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7241 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7237 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7196 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7176 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.717 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7162 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7151 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7124 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7117 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7112 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7097 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.709 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD6663 |
Approved |
0.7067 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7066 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7047 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7047 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7045 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7045 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7039 |
Intermediate Similarity |
NPD5736 |
Approved |
0.7037 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7033 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7033 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7032 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7018 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7013 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD411 |
Approved |
0.7007 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD2654 |
Approved |
0.6995
|
Remote Similarity |
NPD4363 |
Phase 3 |